Pituitary adenylate cyclase-activating peptide and vasoactive intestinal polypeptide bias Langerhans cell Ag presentation toward Th17 cells

European Journal of Immunology

Volumn 42, Issue 4, 2012, Pages 901-911

  Ding, Wanhong ^a   Manni, Michela ^a   Stohl, Lori L ^a   Zhou, Xi K ^a   Wagner, John A ^a   Granstein, Richard D ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cytokines; Langerhans cell; Neuroimmunology; T helper cells

Indexed keywords

GAMMA INTERFERON; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; TH17 CELL;

ANIMALS; ANTIGEN PRESENTATION; CYTOKINES; EPIDERMIS; FEMALE; LANGERHANS CELLS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; SKIN DISEASES; TH1 CELLS; TH17 CELLS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84860259331     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141958     Document Type: Article

References (84)

1. Streilein, J. W. and Bergstresser, P. R., Langerhans cells: antigen presenting cells of the epidermis. Immunobiology 1984. 168: 285-300.
2. Stingl, G., Wolff-Schreiner, E. C., Pichler, W. J., Gschnait, F., Knapp, W. and Wolff, K., Epidermal Langerhans cells bear Fc and C3 receptors. Nature 1977. 268: 245-246.
3. Romani, N., Lenz, A., Glassel, H., Stossel, H., Stanzl, U., Majdic, O., Fritsch, P. et al., Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J. Invest. Dermatol. 1989. 93: 600-609.
4. Lappin, M. B., Kimber, I. and Norval, M., The role of dendritic cells in cutaneous immunity. Arch. Dermatol. Res. 1996. 288: 109-121.
5. Hosoi, J., Murphy, G. F., Egan, C. L., Lerner, E. A., Grabbe, S., Asahina, A. and Granstein, R. D., Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993. 363: 159-163.
6. Asahina, A., Hosoi, J., Beissert, S., Stratigos, A. and Granstein, R. D., Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J. Immunol. 1995. 154: 3056-3061.
7. Ding, W., Stohl, L. L., Wagner, J. A. and Granstein, R. D., Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity. J. Immunol. 2008. 181: 6020-6026.
8. Sherwood, N. M., Krueckl, S. L. and McRory, J. E., The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr. Rev. 2000. 21: 619-670.
9. Laburthe, M. and Couvineau, A., Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP. Regul. Pept. 2002. 108: 165-173.
10. Laburthe, M., Couvineau, A. and Marie, J. C., VPAC receptors for VIP and PACAP. Receptors Channels 2002. 8: 137-153.
11. Fahrenkrug, J., VIP and PACAP. Results Probl. Cell Differ. 2010. 50: 221-234.
12. Schulze, E., Witt, M., Fink, T., Hofer, A. and Funk, R. H., Immunohistochemical detection of human skin nerve fibers. Acta Histochem. 1997. 99: 301-309.
13. Savage, M. V., Brengelmann, G. L., Buchan, A. M. and Freund, P. R., Cystic fibrosis, vasoactive intestinal polypeptide, and active cutaneous vasodilation. J Appl. Physiol. 1990. 69: 2149-2154.
14. Groneberg, D. A., Welker, P., Fischer, T. C., Dinh, Q. T., Grutzkau, A., Peiser, C., Wahn, U. et al., Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. J. Allergy Clin. Immunol. 2003. 111: 1099-1105.
15. Kodali, S., Friedman, I., Ding, W., Seiffert, K., Wagner, J. A. and Granstein, R. D., Pituitary adenylate cyclase-activating polypeptide inhibits cutaneous immune function. Eur. J. Immunol. 2003. 33: 3070-3079.
16. Kodali, S., Ding, W., Huang, J., Seiffert, K., Wagner, J. A. and Granstein, R. D., Vasoactive intestinal peptide modulates Langerhans cell immune function. J. Immunol. 2004. 173: 6082-6088.
17. Ding, W., Wagner, J. A. and Granstein, R. D., CGRP, PACAP, and VIP modulate Langerhans cell function by inhibiting NF-kappaB activation. J. invest. dermatol. 2007. 127: 2357-2367.
18. Mosmann, T. R. and Coffman, R. L., Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 1989. 46: 111-147.
19. Mosmann, T. R. and Coffman, R. L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989. 7: 145-173.
20. Peck, A. and Mellins, E. D., Precarious balance: Th17 cells in host defense. Infect. Immun. 2010. 78: 32-38.
21. Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., Cianfarani, F. et al., Th22 cells represent a distinct human T-cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 2009. 119: 3573-3585.
22. Annunziato, F. and Romagnani, S., Heterogeneity of human effector CD4+ T cells. Arthritis Res. Ther. 2009. 11: 257.
23. Ivanov, II, McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J. et al., The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006. 126: 1121-1133.
24. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. et al., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
25. Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F. et al., Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007. 8: 639-646.
26. Khader, S. A., Bell, G. K., Pearl, J. E., Fountain, J. J., Rangel-Moreno, J., Cilley, G. E., Shen, F. et al., IL-23 and IL-17 in the establishment of protective pulmonary CD4 +T-cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 2007. 8: 369-377.
27. Tesmer, L. A., Lundy, S. K., Sarkar, S. and Fox, D. A., Th17 cells in human disease. Immunol. Rev. 2008. 223: 87-113.
28. Zaba, L. C., Cardinale, I., Gilleaudeau, P., Sullivan-Whalen, M., Suarez-Farinas, M., Fuentes-Duculan, J., Novitskaya, I. et al., Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 2007. 204: 3183-3194.
29. Zaba, L. C., Fuentes-Duculan, J., Eungdamrong, N. J., Abello, M. V., Novitskaya, I., Pierson, K. C., Gonzalez, J. et al., Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J. Invest. Dermatol. 2009. 129: 79-88.
30. Lowes, M. A., Kikuchi, T., Fuentes-Duculan, J., Cardinale, I., Zaba, L. C., Haider, A. S., Bowman, E. P. et al., Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 2008. 128: 1207-1211.
31. Harper, E. G., Guo, C., Rizzo, H., Lillis, J. V., Kurtz, S. E., Skorcheva, I., Purdy, D. et al., Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J. Invest. Dermatol. 2009. 129: 2175-2183.
32. Piskin, G., Sylva-Steenland, R. M., Bos, J. D. and Teunissen, M. B., In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J. Immunol. 2006. 176: 1908-1915.
33. Neuner, P., Urbanski, A., Trautinger, F., Moller, A., Kirnbauer, R., Kapp, A., Schopf, E. et al., Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J. Invest. Dermatol. 1991. 97: 27-33.
34. Grossman, R. M., Krueger, J., Yourish, D., Granelli-Piperno, A., Murphy, D. P., May, L. T., Kupper, T. S. et al., Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. USA 1989. 86: 6367-6371.
35. Asahina, A., Moro, O., Hosoi, J., Lerner, E. A., Xu, S., Takashima, A. and Granstein, R. D., Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects. Proc. Natl. Acad. Sci. USA 1995. 92: 8323-8327.
36. Murphy, K. M., Heimberger, A. B. and Loh, D. Y., Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 1990. 250: 1720-1723.
37. Hsieh, C. S., Heimberger, A. B., Gold, J. S., O'Garra, A. and Murphy, K. M., Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system. Proc. Natl Acad Sci USA 1992. 89: 6065-6069.
38. Ouyang, W., Kolls, J. K. and Zheng, Y., The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008. 28: 454-467.
39. Spolski, R. and Leonard, W. J., Cytokine mediators of Th17 function. Eur. J. Immunol. 2009. 39: 658-661.
40. Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J. and Ouyang, W., Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007. 445: 648-651.
41. Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suarez-Farinas, M., Cardinale, I., Khatcherian, A. et al., Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 2008. 159: 1092-1102.
42. Boniface, K., Guignouard, E., Pedretti, N., Garcia, M., Delwail, A., Bernard, F. X., Nau, F. et al., A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin. Exp. Immunol. 2007. 150: 407-415.
43. Kagami, S., Rizzo, H. L., Lee, J. J., Koguchi, Y. and Blauvelt, A., Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J. Invest. Dermatol. 2010. 130: 1373-1383.
44. Ma, H. L., Liang, S., Li, J., Napierata, L., Brown, T., Benoit, S., Senices, M. et al., IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J. Clin. Invest. 2008. 118: 597-607.
45. Lee, S. H., Jeong, S. K. and Ahn, S. K., An update of the defensive barrier function of skin. Yonsei Med. J. 2006. 47: 293-306.
46. Fortune, D. G., Richards, H. L. and Griffiths, C. E., Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol. Clin. 2005. 23: 681-694.
47. Arndt, J., Smith, N. and Tausk, F., Stress and atopic dermatitis. Curr. Allergy Asthma Rep. 2008. 8: 312-317.
48. Reich, A., Wojcik-Maciejewicz, A. and Slominski, A. T., Stress and the skin. G Ital. Dermatol. Venereol. 2010. 145: 213-219.
49. Dewing, S. B., Remission of psoriasis associated with cutaneous nerve section. Arch. Dermatol. 1971. 104: 220-221.
50. Mulherin, D., Bresnihan, B. and FitzGerald, O., Digital denervation associated with absence of nail and distal interphalangeal joint involvement in psoriatic arthritis. J. Rheumatol. 1995. 22: 1211-1212.
51. Farber, E. M., Lanigan, S. W. and Boer, J., The role of cutaneous sensory nerves in the maintenance of psoriasis. Int. J. Dermatol. 1990. 29: 418-420.
52. Homey, B., Dieu-Nosjean, M. C., Wiesenborn, A., Massacrier, C., Pin, J. J., Oldham, E., Catron, D. et al., Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 2000. 164: 6621-6632.
53. Albanesi, C., Cavani, A. and Girolomoni, G., IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J. Immunol. 1999. 162: 494-502.
54. Guilliams, M., Henri, S., Tamoutounour, S., Ardouin, L., Schwartz-Cornil, I., Dalod, M. and Malissen, B., From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur. J. Immunol. 2010. 40: 2089-2094.
55. Igyarto, B. Z., Haley, K., Ortner, D., Bobr, A., Gerami-Nejad, M., Edelson, B. T., Zurawski, S. M. et al., Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 2011. 35: 260-272.
56. + T cells but are incapable of cross-presentation. Eur. J. Immunol. 2011. 41: 2619-2631.
57. Azukizawa, H., Dohler, A., Kanazawa, N., Nayak, A., Lipp, M., Malissen, B., Autenrieth, I. et al., Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+ CD25 +Foxp3+ regulatory T cells. Eur. J. Immunol. 2011. 41: 1420-1434.
58. Ward, N. L., Loyd, C. M., Wolfram, J. A., Diaconu, D., Michaels, C. M. and McCormick, T. S., Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice. Br. J. Dermatol. 2011. 164: 750-758.
59. Aliahmadi, E., Gramlich, R., Grutzkau, A., Hitzler, M., Kruger, M., Baumgrass, R., Schreiner, M. et al., TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23. Eur. J. Immunol. 2009. 39: 1221-1230.
60. Fujita, H., Nograles, K. E., Kikuchi, T., Gonzalez, J., Carucci, J. A. and Krueger, J. G., Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc. Natl. Acad. Sci. USA 2009. 106: 21795-21800.
61. Trifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K. and Spits, H., Identification of a human helper T-cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 2009. 10: 864-871.
62. Nograles, K. E., Zaba, L. C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., Ramon, M. et al., IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J. Allergy Clin. Immunol. 2009. 123: 1244-1252 e1242.
63. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. and Sallusto, F., Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 2009. 10: 857-863.
64. Wolk, K. and Sabat, R., Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 2006. 17: 367-380.
65. Sabat, R. and Wolk, K., Research in practice: IL-22 and IL-20: significance for epithelial homeostasis and psoriasis pathogenesis. J. Dtsch. Dermatol. Ges. 2011. 9: 518-523.
66. Boniface, K., Bernard, F. X., Garcia, M., Gurney, A. L., Lecron, J. C. and Morel, F., IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 2005. 174: 3695-3702.
67. Sa, S. M., Valdez, P. A., Wu, J., Jung, K., Zhong, F., Hall, L., Kasman, I. et al., The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J. Immunol. 2007. 178: 2229-2240.
68. Gurney, A. L., IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int. Immunopharmacol. 2004. 4: 669-677.
69. Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K. and Sabat, R., IL-22 increases the innate immunity of tissues. Immunity 2004. 21: 241-254.
70. Delgado, M., Leceta, J., Gomariz, R. P. and Ganea, D., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression. J. Immunol. 1999. 163: 3629-3635.
71. Delgado, M. and Ganea, D., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression. J. Immunol. 2000. 164: 1200-1210.
72. Jacobson, N. G., Szabo, S. J., Guler, M. L., Gorham, J. D. and Murphy, K. M., Regulation of interleukin-12 signalling during T helper phenotype development. Adv. Exp. Med. Biol. 1996. 409: 61-73.
73. Kunz, M. and Ibrahim, S. M., Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm. 2009. 2009: 979258.
74. Koenders, M. I. and van den Berg, W. B., Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity? Clin. Exp. Immunol. 2010. 159: 131-136.
75. Liu, Z. J., Yadav, P. K., Su, J. L., Wang, J. S. and Fei, K., Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J. Gastroenterol. 2009. 15: 5784-5788.
76. Ji, Y. and Zhang, W., Th17 cells: positive or negative role in tumor? Cancer Immunol. Immunother. 2010. 59: 979-987.
77. Murugaiyan, G. and Saha, B., Protumor vs antitumor functions of IL-17. J. Immunol. 2009. 183: 4169-4175.
78. Peters, E. M., Ericson, M. E., Hosoi, J., Seiffert, K., Hordinsky, M. K., Ansel, J. C., Paus, R. et al., Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J. Invest. Dermatol. 2006. 126: 1937-1947.
79. Mulder, H., Jongsma, H., Zhang, Y., Gebre-Medhin, S., Sundler, F. and Danielsen, N., Pituitary adenylate cyclase-activating polypeptide and islet amyloid polypeptide in primary sensory neurons: functional implications from plasticity in expression on nerve injury and inflammation. Mol. Neurobiol. 1999. 19: 229-253.
80. Naukkarinen, A., Jarvikallio, A., Lakkakorpi, J., Harvima, I. T., Harvima, R. J. and Horsmanheimo, M., Quantitative histochemical analysis of mast cells and sensory nerves in psoriatic skin. J. Pathol. 1996. 180: 200-205.
81. Pincelli, C., Fantini, F., Romualdi, P., Sevignani, C., Lesa, G., Benassi, L. and Giannetti, A., Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. J. Invest. Dermatol. 1992. 98: 421-427.
82. Umemoto, N., Kakurai, M., Okazaki, H., Kiyosawa, T., Demitsu, T. and Nakagawa, H., Serum levels of vasoactive intestinal peptide are elevated in patients with atopic dermatitis. J. Dermatol. Sci. 2003. 31: 161-164.
83. Grzybowska-Chlebowczyk, U., Wos, H., Szymanska, M. and Kajor, M., Basal concentration of Substance P (SP) and Vasoactive Intestinal Peptide (VIP) in the blood serum of children with allergic dermatitis. Med Wieku Rozwoj. 2003. 7: 43-48.
84. Hothorn, T., Bretz, F. and Westfall, P., Simultaneous inference in general parametric models. Biom J. 2008. 50: 346-363.